Intensive Chemotherapy for Acute Lymphoblastic Leukaemia in Adults
High-dose cytosine arabinoside (HD Ara-C) has been shown to induce complete remission in acute lymphoblastic leukaemia (ALL) which is refractory to, or which has recurred following conventional therapy [1–5]. This study was undertaken to determine whether the incorporation of HD Ara-C at a dose of 2 g/m2 twice daily for 6 days into the treatment previously used at St. Bartholomew’s Hospital (OPAL)  would improve the prognosis of adults with ALL.
KeywordsAcute Lymphoblastic Leukaemia Acute Leukaemia Cytosine Arabinoside Blast Count High Dose Cytosine Arabinoside
Unable to display preview. Download preview PDF.
- 5.de Marsh RW, Wozniak A, McCarley D (1987) Therapy of relapsed acute lymphoblastic leukaemia: a 5 year experience with high dose ara-C. Proc Am Assoc Cancer Res Am Soc Clin Oncol 6:147 (in Proc Am Soc Cl in Oncol)Google Scholar
- 6.Lister TA, Whitehouse JMA, Beard MEJ et al. (1978) Combination chemotherapy for acute lymphoblastic leukaemia in adults. Br Med J: 199–203Google Scholar
- 7.Barnett MJ, Greaves MF, Amess JAL et al. (1976) Treatment of acute lymphoblastic leukaemia in adults. Br J Haematol 33: 455–468Google Scholar
- 12.Cox DR (1972) Regression models and lifetables. R Stat Soc [B] 34: 187–220Google Scholar